FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117547860> ?p ?o ?g. }

• W2117547860 endingPage "487" @default.
• W2117547860 startingPage "482" @default.
• W2117547860 abstract "Purpose Complete remission (CR) is uncommon during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs), but it may occur in some patients. It remains a matter of debate whether therapy should be continued after CR. Methods A multicenter, retrospective analysis of a series of patients with mRCC who obtained CR during treatment with TKIs (sunitinib or sorafenib), either alone or with local treatment (surgery, radiotherapy, or radiofrequency ablation), was performed. Results CR was identified in 64 patients; 36 patients had received TKI treatment alone and 28 had also received local treatment. Most patients had clear cell histology (60 of 64 patients), and all had undergone previous nephrectomy. The majority of patients were favorable or intermediate risk; however, three patients were poor risk. Most patients developed CR during sunitinib treatment (59 of 64 patients). Among the 36 patients who achieved CR with TKI alone, eight continued TKI treatment after CR, whereas 28 stopped treatment. Seventeen patients who stopped treatment (61%) are still in CR, with a median follow-up of 255 days. Among the 28 patients in CR after TKI plus local treatment, 25 patients stopped treatment, and 12 of these patients (48%) are still in CR, with a median follow-up of 322 days. Conclusion CR can occur after TKI treatment alone or when combined with local treatment. CR was observed at every metastatic site and in every prognostic group." @default.
• W2117547860 created "2016-06-24" @default.
• W2117547860 creator A5002114271 @default.
• W2117547860 creator A5018519159 @default.
• W2117547860 creator A5020353650 @default.
• W2117547860 creator A5021549650 @default.
• W2117547860 creator A5035139653 @default.
• W2117547860 creator A5040479101 @default.
• W2117547860 creator A5042461515 @default.
• W2117547860 creator A5044169031 @default.
• W2117547860 creator A5047019507 @default.
• W2117547860 creator A5048862211 @default.
• W2117547860 creator A5048921562 @default.
• W2117547860 creator A5049649140 @default.
• W2117547860 creator A5049672639 @default.
• W2117547860 creator A5051297483 @default.
• W2117547860 creator A5067036952 @default.
• W2117547860 creator A5074162105 @default.
• W2117547860 date "2012-02-10" @default.
• W2117547860 modified "2023-10-09" @default.
• W2117547860 title "Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma" @default.
• W2117547860 cites W165231543 @default.
• W2117547860 cites W1974417641 @default.
• W2117547860 cites W1998045802 @default.
• W2117547860 cites W1998081924 @default.
• W2117547860 cites W1999626758 @default.
• W2117547860 cites W1999966467 @default.
• W2117547860 cites W2016569548 @default.
• W2117547860 cites W2025313611 @default.
• W2117547860 cites W2039136437 @default.
• W2117547860 cites W2099088585 @default.
• W2117547860 cites W2115005218 @default.
• W2117547860 cites W2118677643 @default.
• W2117547860 cites W2123914905 @default.
• W2117547860 cites W2137822543 @default.
• W2117547860 cites W2151637779 @default.
• W2117547860 cites W2153867442 @default.
• W2117547860 cites W2158496491 @default.
• W2117547860 cites W2160120519 @default.
• W2117547860 cites W2160476851 @default.
• W2117547860 cites W2160926061 @default.
• W2117547860 cites W2162352067 @default.
• W2117547860 cites W2162424705 @default.
• W2117547860 cites W2164638888 @default.
• W2117547860 cites W2171469612 @default.
• W2117547860 cites W2260803059 @default.
• W2117547860 cites W4234636179 @default.
• W2117547860 doi "https://doi.org/10.1200/jco.2011.37.2516" @default.
• W2117547860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22231040" @default.
• W2117547860 hasPublicationYear "2012" @default.
• W2117547860 type Work @default.
• W2117547860 sameAs 2117547860 @default.
• W2117547860 citedByCount "147" @default.
• W2117547860 countsByYear W21175478602012 @default.
• W2117547860 countsByYear W21175478602013 @default.
• W2117547860 countsByYear W21175478602014 @default.
• W2117547860 countsByYear W21175478602015 @default.
• W2117547860 countsByYear W21175478602016 @default.
• W2117547860 countsByYear W21175478602017 @default.
• W2117547860 countsByYear W21175478602018 @default.
• W2117547860 countsByYear W21175478602019 @default.
• W2117547860 countsByYear W21175478602020 @default.
• W2117547860 countsByYear W21175478602021 @default.
• W2117547860 countsByYear W21175478602022 @default.
• W2117547860 countsByYear W21175478602023 @default.
• W2117547860 crossrefType "journal-article" @default.
• W2117547860 hasAuthorship W2117547860A5002114271 @default.
• W2117547860 hasAuthorship W2117547860A5018519159 @default.
• W2117547860 hasAuthorship W2117547860A5020353650 @default.
• W2117547860 hasAuthorship W2117547860A5021549650 @default.
• W2117547860 hasAuthorship W2117547860A5035139653 @default.
• W2117547860 hasAuthorship W2117547860A5040479101 @default.
• W2117547860 hasAuthorship W2117547860A5042461515 @default.
• W2117547860 hasAuthorship W2117547860A5044169031 @default.
• W2117547860 hasAuthorship W2117547860A5047019507 @default.
• W2117547860 hasAuthorship W2117547860A5048862211 @default.
• W2117547860 hasAuthorship W2117547860A5048921562 @default.
• W2117547860 hasAuthorship W2117547860A5049649140 @default.
• W2117547860 hasAuthorship W2117547860A5049672639 @default.
• W2117547860 hasAuthorship W2117547860A5051297483 @default.
• W2117547860 hasAuthorship W2117547860A5067036952 @default.
• W2117547860 hasAuthorship W2117547860A5074162105 @default.
• W2117547860 hasConcept C121608353 @default.
• W2117547860 hasConcept C126322002 @default.
• W2117547860 hasConcept C141071460 @default.
• W2117547860 hasConcept C2777472916 @default.
• W2117547860 hasConcept C2778019345 @default.
• W2117547860 hasConcept C2778695046 @default.
• W2117547860 hasConcept C2778820342 @default.
• W2117547860 hasConcept C2779490328 @default.
• W2117547860 hasConcept C71924100 @default.
• W2117547860 hasConcept C90924648 @default.
• W2117547860 hasConceptScore W2117547860C121608353 @default.
• W2117547860 hasConceptScore W2117547860C126322002 @default.
• W2117547860 hasConceptScore W2117547860C141071460 @default.
• W2117547860 hasConceptScore W2117547860C2777472916 @default.
• W2117547860 hasConceptScore W2117547860C2778019345 @default.
• W2117547860 hasConceptScore W2117547860C2778695046 @default.

• next